Simon Malpas 

As a young researcher, Simon wasn’t satisfied with publishing papers. Driven by curiosity and trying to make sense of the human body under stress, Simon knew he wanted his science to save lives. When he first heard neurosurgeons describe the fear patients with hydrocephalus, a condition where fluid gathers in the brain, face every time they get a headache, he couldn’t unhear it. The realisation that doctors had no reliable way to monitor brain pressure sparked a new direction for Simon, and Kitea Health was created in 2022.

With decades of experience in physiological monitoring, Simon set out to solve a problem labelled as too complex, and worked to develop the world’s first wireless, battery-free, micro-implantable device that can monitor pressure deep inside the brain. His first product, the Kitea System, helps patients avoid unnecessary hospital visits and gives doctors the data they need to make informed decisions about care. 

In 2024, Kitea treated its first patients and secured FDA Breakthrough Device Designation, as one of only 63 companies globally to do so. With accessibility at the heart of Simon’s drive, Kitea also joined the FDA’s TAP programme, helping smooth regulatory and reimbursement pathways. 

As a long-term academic and innovator, Simon has helped shape the future of research translation, mentored hundreds of students, and strengthened the link between research and industry. He has also partnered with CureKids and backed initiatives that bring Māori and Pasifika perspectives into science. 

Simon is transforming healthcare from reactive to preventative. Kitea’s core technology has wider applications in managing other high-burden and chronic conditions like heart failure and cardiovascular monitoring. Simon’s commitment to care has contributed to a stronger, more collaborative innovation ecosystem, where knowledge is shared, and purpose remains at the core – using science to save lives.